, /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the The is estimated to reach over , exhibiting a CAGR of 17.
9% during the forecast period. Exosomes, a form of nanoparticle also referred to as small extracellular vesicles, are gathering attention as potential novel therapeutics for a variety of diseases due to their capacity to deliver genetic or bioactive molecules to recipient cells. Exosomes have demonstrated potential in diagnosing, monitoring, and treating various conditions, including certain cancers, cardiopulmonary diseases, and neurodegenerative disorders.
Although numerous pharmaceutical companies are progressively developing exosome therapeutics, innumerable obstacles remain to overcome in producing clinical-grade exosomes for therapeutic purposes. Exosome manufacturing focuses on scaling up production yields and ensuring high purity, enhancing manufacturing efficiency and outcomes to meet the growing demand for exosomes. Exosomes naturally facilitate intercellular communication, making them highly efficient carriers of biological signals and therapeutic molecules.
A significant surge in academic and clinical research focused on understanding exosome biology and its potential applications is driving the market. The development of regulatory frameworks for exosome-based products by key agencies such as the FDA and EMA is playing a crucial role in facilitating market growth. The ability to tailor exosome-based th.
